Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory bowel disease: management issues during pregnancy

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Introduction

Inflammatory bowel disease often affects women during their reproductive years, causing management concerns for obstetricians caring for these patients during pregnancy.

Treatment

Apart from methotrexate, most drugs used regularly to treat ulcerative colitis and Crohn's disease can safely be used by pregnant women. No causal relationship has been established between exposure to sulfasalazine or other 5-aminosalicylic acid drugs and the development of congenital malformations and these drugs may be used with relative safety during pregnancy and lactation. Current evidence indicates that maternal use of azathioprine and mercaptopurine is not associated with an increased risk of congenital malformations, though impaired foetal immunity, intrauterine growth retardation and prematurity are occasionally observed. Cyclosporin is not teratogenic, but may be associated with growth retardation and prematurity.

Conclusions

Pregnancy should be avoided in women treated with methotrexate because of its known abortifacient effects and risk of causing typical malformations. There is no actual evidence of adverse effect in pregnant women receiving Infliximab but the amount of clinical information is small. The treatment with metronidazole or ciprofloxacin for short durations appear to be safe, but there is no data about the effects of increased length of treatment as required in Crohn's disease remains unknown. Control of disease activity before conception and during pregnancy is critical to optimise both maternal and foetal health. A multidisciplined approach involving both obstetrician and gastroenterologist and education about pregnancy are essential components of the treatment of any young women with IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramson D, Jankelson IR, Milner LR (1951) Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol 61:121–129

    Google Scholar 

  2. Alstead EM, Ritchie JR, Lennard-Jones JE, Farthing MJG, Clark MI (1990) Safety of azathioprine in pregnancy and inflammatory bowel disease. Gastroenterology 99:443–446

    CAS  PubMed  Google Scholar 

  3. American College of Obstetricians and Gynecologists, Committee on Obstetrics Practice (1995) Guidelines for diagnostic imaging during pregnancy. ACOG Committee opinion no. 158, Washington, DC

  4. Baiocco PJ, Korelitz BI (1984) The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 6:211–216

    CAS  PubMed  Google Scholar 

  5. Baird DD, Narendranathan M, Sandler RS (1990) Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99:987–994

    CAS  PubMed  Google Scholar 

  6. Bell CM, Habal FM (1997) Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol 92:2201–2202

    PubMed  Google Scholar 

  7. Berkovitch M, Pastuszak A, Gazarian M, Gazarian M, Lewis M, Koren G (1994) Safety of the new quinolones in pregnancy. Obstet Gynecol 84:535–538

    PubMed  Google Scholar 

  8. Bermas BL, Hill JA (1995) Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 17:1722–1732

    Google Scholar 

  9. Boulton R, Hamilton M, Lewis A, Walker P, Pounder R (1994) Fulminant ulcerative colitis in pregnancy. Am J Gastroenterol 89:931–933

    PubMed  Google Scholar 

  10. Burakoff R, Opper F (1995) Pregnancy and nursing. Gastroenterol Clin N Am 24:689–698

    CAS  Google Scholar 

  11. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G (1995) Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 172:525–529

    CAS  PubMed  Google Scholar 

  12. Cappell MS, Colon VJ, Sidhom OA (1996) A study of 10 medical centres of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 41:2353–2361

    CAS  PubMed  Google Scholar 

  13. Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, Delcroix M (1994) Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet 344:620–621

    PubMed  Google Scholar 

  14. Committee on Drugs, American Academy of Pediatrics (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108:776–779

    PubMed  Google Scholar 

  15. Connell W, Miller A (1999) Treating inflammatory bowel disease during pregnancy: risks and safety of therapy. Drug Saf 21:311–323

    CAS  PubMed  Google Scholar 

  16. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110:424–431

    CAS  Google Scholar 

  17. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, Traina M, Tonelli F, Pagliaro L (1994) Smoking habits and recurrence in Crohn's disease. Gastroenterology 106:643–648

    PubMed  Google Scholar 

  18. Craxi A, Pagliarello F (1980) Possible embryotoxicity of sulphasalazine. Arch Intern Med 140:1674

    CAS  Google Scholar 

  19. Czeizel AE, Toth M, Rockenbauer M (1996) Population-based case-control study of folic acid supplementation during pregnancy. Teratology 53:345–351

    Article  CAS  PubMed  Google Scholar 

  20. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G (1998) The safety of mesalazine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114:23–28

    CAS  PubMed  Google Scholar 

  21. Diniz EM, Corradini HB, Ramas JL, Brock R (1978) Effect on the fetus of methotrexate administered to the mother: presentation of a case. Rev Hosp Clin Fac Sao Paulo 33:286–290

    CAS  Google Scholar 

  22. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G (1994) Methotrexate exposure prior to and during pregnancy. Teratology 49:79–81

    PubMed  Google Scholar 

  23. Fedorokow DM, Persaud D, Nimrod CA (1989) Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 4:998–1001

    Google Scholar 

  24. Fielding JF, Cooke WT (1970) Pregnancy and Crohn's disease. BMJ 2:76–77

    CAS  PubMed  Google Scholar 

  25. Frank B (1994) Endoscopy during pregnancy. In: Karlsadt RG, Croitoru R (ed) Gastrointestinal disorders during pregnancy. American College of Gastroenterology, Arlington, VA, pp 24–29

  26. Friedman S, Regueiro MD (2002) Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am 31:265–273

    PubMed  Google Scholar 

  27. Guillibrand PN (1966) Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc R Soc Med 59:834

    Google Scholar 

  28. Hanan I (1993) Inflammatory bowel disease in the pregnant woman. Compr Ther 19:91–95

    CAS  PubMed  Google Scholar 

  29. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343:1608–1614

    PubMed  Google Scholar 

  30. Hill J, Clark A, Scott NA (1998) Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med 90:64–66

    Google Scholar 

  31. Hoo JJ, Hadro TA, von Behren P (1988) Possible teratogenicity of sulfasalazine. N Engl J Med 318:1128–1129

    CAS  Google Scholar 

  32. Ilnyckyj A, Blanchard JF, Rawsthorne P, Bernstein CN (1999) Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 94:3274–3278

    PubMed  Google Scholar 

  33. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G (1993) Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 168:1393–1399

    CAS  PubMed  Google Scholar 

  34. Janssen NM, Genta SG (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch Intern Med 160:610–619

    CAS  PubMed  Google Scholar 

  35. Järnerot G (1993) Management of IBD in pregnancy. Res Clin Forum 15:137–143

    Google Scholar 

  36. Järnerot G, Into-Malberg MB, Esbjorner E (1981) Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 16:693–697

    PubMed  Google Scholar 

  37. Keighley MR, Grobler S, Bain I (1993) An audit of restorative proctocolectomy. Gut 34:680–684

    CAS  PubMed  Google Scholar 

  38. Khosla R, Willoughby CP, Jewell DP (1984) Crohn's disease and pregnancy. Gut 25:52–56

    CAS  PubMed  Google Scholar 

  39. Korelitz BI (1985) Pregnancy, fertility, and inflammatory bowel disease. Am J Gastroenterol 80:365–370

    CAS  PubMed  Google Scholar 

  40. Korelitz BI (1992) Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am 21:827–834

    CAS  Google Scholar 

  41. Korelitz BI, Glass JL, Wisch N (1973) Long term immunosuppressive therapy of ulcerative colitis: continuation of a personal series. Am J Dig Dis 18:317–322

    PubMed  Google Scholar 

  42. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal Am (1990) Outcome of first trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88:589–592

    CAS  PubMed  Google Scholar 

  43. Kucerova M, Kocandrle V, Matousek V, Polikova Z, Reneltova I (1982) Chromosomal aberrations and sister-chromatid exchanges (SCEs) in patients undergoing long-term Imuran therapy. Mutat Res 94:501–509

    CAS  PubMed  Google Scholar 

  44. Lambers DF, Clark KE (1996) The maternal and fetal physiologic effects of nicotine. Semin Perinatol 20:115–126

    CAS  PubMed  Google Scholar 

  45. Lewis JH, Weingold AB (1985) The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol 80:912–923

    CAS  PubMed  Google Scholar 

  46. Marteau P, Tennenbaum R, Elefant E, Lémann M, Cosnes J (1998) Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 12:1101–1108

    CAS  PubMed  Google Scholar 

  47. Martimbeau PW, Welch JS, Weiland LH (1975) Crohn's disease and pregnancy. Am J Obstet Gynecol 122:746–749

    CAS  PubMed  Google Scholar 

  48. McEwan HP (1972) Ulcerative colitis in pregnancy. Proc R Soc Med 65:279–281

    CAS  PubMed  Google Scholar 

  49. Miller JP (1986) Inflammatory bowel disease in pregnancy: a review. J R Soc Med 79:221–229

    CAS  PubMed  Google Scholar 

  50. Milunsky A, Graef JW, Gaynor MF (1968) Methotrexate-induced congenital malformations. J Pediatr 72:790–795

    CAS  PubMed  Google Scholar 

  51. Modigliani R (1997) Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol 9:854–857

    CAS  PubMed  Google Scholar 

  52. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW (1981) Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 80:72–76

    CAS  PubMed  Google Scholar 

  53. Moser MAJ, Okun NB, Mayes DC, Bailey RJ (2000) Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 95:1021–1026

    CAS  PubMed  Google Scholar 

  54. Nelis GF (1989) Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet 1:383

    Google Scholar 

  55. Newman NM, Correy JF (1983) Possible teratogenicity of sulphasalazine. Med J Aust 1:528–529

    Google Scholar 

  56. Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ (2002) Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol 99:599–602

    Google Scholar 

  57. Nielsen OH, Andreasson B, Bondensen S, Jarnum S (1983) Pregnancy in ulcerative colitis. Scand J Gastroenterol 18:735–742

    Google Scholar 

  58. Nielsen OH, Andreasson B, Bondensen S, Jacobsen O (1984) Pregnancy in Crohn's disease. Scand J Gastroenterol 19:724–732

    Google Scholar 

  59. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeerts P (1996) Familial aggregation in Crohn's disease. Increased age, adjusted risk and concordance in clinical characteristics. Gastroenterology 111:597–603

    CAS  PubMed  Google Scholar 

  60. Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE (1971) Parenthood in renal transplant recipients. JAMA 216:1755–1761

    Google Scholar 

  61. Piper JM, Mitchell EF, Ray WA (1993) Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 82:348–352

    Google Scholar 

  62. Powell HR, Ekert H (1971) Methotrexate-induced congenital malformations. Med J Aust 2:1076–1077

    Google Scholar 

  63. Radomski JS, Ahlswede BA, Jarrell BE, Mannion J, Cater J, Moritz MJ, Armenti VT (1995) Outcomes of 500 pregnancies in 335 female kidney, liver and heart transplant recipients. Transplant Proc 27:1089–1090

    Google Scholar 

  64. Rogers BH, Clark LM, Kirsner JB (1971) The epidemiologic and demographic characteristic of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 24:743–773

    Google Scholar 

  65. Rosenkrantz JG, Githens JH, Cox SM, Kellum DL (1967) Azathioprine (Imuran) in pregnancy. Am J Obstet Gynecol 97:708–710

    Google Scholar 

  66. Saarokoski S, Seppala M (1973) Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to fetus. Am J Obstet Gynecol 115:1100–1106

    Google Scholar 

  67. Sagar P, Lewis W, Holdsworth P, Johnston D, Mitchell C, MacFie J (1993) Quality of life after restorative proctocolectomy with a pelvicileal reservoir compares favourably with that of patients with medically treated colitis. Dis Colon Rectum 36:584–592

    Google Scholar 

  68. Schofield PF, Turnbull RB, Hawk WA (1970) Crohn's disease and pregnancy. BMJ 2:364

    Google Scholar 

  69. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB (1993) MRI in the diagnosis of Crohn's disease in two pregnant women. J Clin Gastroenterol 17:244–247

    Google Scholar 

  70. Srinivasan R (2001) Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 96:2274–2275

    Google Scholar 

  71. Subhani JM, Hamilton MI (1998) Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 12:1039–1153

    Google Scholar 

  72. Teahon K, Pearson M, Levi AJ, Bjarnason I (1991) Elemental diet in the management of Crohn's disease during pregnancy. Gut 32:1079–1081

    Google Scholar 

  73. Tuchmann-Duplessis H, Mercier-Parot L (1966) Production in rabbits of malformations of the limbs by azathioprine and 6-mercaptopurine. C R Soc Biol 166:501–506

    Google Scholar 

  74. Willoughby CP, Truelove SC (1980) Ulcerative colitis and pregnancy. Gut 21:469–474

    Google Scholar 

  75. Woolfson K, Cohen Z, McLeod S (1990) Crohn's disease and pregnancy. Dis Colon Rectum 33:869–873

    Google Scholar 

  76. Zeldis J (1989) Pregnancy and inflammatory bowel disease. West J Med 151:168–171

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Ostetricia e Ginecologia, Università degli Studi di Genova, Padiglione 1, Ospedale San Martino, Largo R. Benzi 1, 16132, Genova, Italy

    Simone Ferrero & Nicola Ragni

Authors
  1. Simone Ferrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola Ragni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simone Ferrero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrero, S., Ragni, N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet 270, 79–85 (2004). https://doi.org/10.1007/s00404-003-0489-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-003-0489-6

Keywords

Search

Navigation